Researchers have added fresh evidence that early exposure to vaccine-, bacterial- or microbiota-derived antigens has a dramatic effect on the diversity of antibodies an adult mammal will have to fight future infections by pathogens. This antibody diversity is called the clonal repertoire — basically different single cells with distinct antibody potential that can multiply into a large clone of cells, all producing that distinct antibody.